Press Releases
Upcoming Events
Philogen to attend the Antibody Engineering & Therapeutics Europe 2023 in Amsterdam on June 6-8, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 6th of June 2023 entitled “Immunocytokines with Activity on Demand”. Dr. Roberto De Luca (Head of Antibody...
Read morePhilochem to attend the 71st American Society for Mass Spectrometry Conference on June 4-8, 2023
Dr. Ettore Gilardoni (Head of Bio-MS) will present a poster entitled: Proteomic analysis reveals insights into the mechanism of the Intra-cork approach for increasing therapeutic window of immunocytokines Domenico Ravazza,...
Read morePhilogen to attend the Immuno-Oncology Summit Europe 2023 in London, on June 20-22, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 20th of June 2023 entitled “Antibody-Cytokine Fusions Targeting the Tumor Microenvironment: Lessons Learned from Clinical Results”. Follow...
Read morePast Events
Philogen kindly invites you to attend a virtual briefing for analysts on 5 June 2023 to discuss the Company’s latest updates.
Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, will host a 1-hour live webcast and conference call...
Read morePhilogen to attend the 74th Mosbacher Kolloquium in Mosbach/Baden, on March 23-25, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 23rd of March 2023 entitled “Novel developments on immunocytokines”
Follow the link for more details.
Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Matilde Bocci, Eleonora Prodi, Sara Puglioli, Giulia Rotta and Aureliano...
Read more